|Mouse Molecular Genetics - URA CNRS 2578|
|Director : Philip AVNER (firstname.lastname@example.org)|
Research in the Unit is centred around three topics :
1) Epigenetics and the Inactivation of the mouse X chromosome
2) Multifactorial Genetics and the Genetic analysis of type 1 diabetes in the mouse.
3) Stem Cells and the role of the X-linked gene Nap1l2 in the control of neuronal stem cell proliferation
1) Epigenetics and the Inactivation of the mouse X chromosome
One of the major research interests of the Mouse Molecular Genetics Unit is X chromosome inactivation. This is a complex biological process which depends on the presence of the X-inactivation centre (Xic) and which results in the inactivation of one of the two X chromosomes present in the female cell. The process involves both the sensing and counting of the number of X chromosomes in the cell in relation to the autosomal complement and a choice process concerning the X to inactivate. Whilst several genetic elements including the genetically identified locus Xce (X-controlling element) seem to be able to affect the choice of which X chromosome will be chosen to be inactivated, little is known about the factors involved in the counting process. The Xic increasingly appears as a complex control region with multiple elements feeding into the regulation and interactions with the Xist (X-inactive specific transcript) gene which codes for a large non-coding RNA which plays a critical role in the initiation of the inactivation process.
A major part of the work in the laboratory is concerned with the functional identification and analysis of the various components of the Xic involved in the counting and choice mechanisms. Our double approach strategy exploits on the one hand, the creation of novel mutations by targeted mutagenesis using the cre-lox system, and on the other the complementation of pre-existing engineered deletions. Use of the complementation or so-called add-back strategy has allowed us to localise the counting element(s) to a 20kb candidate region. Insight into the role of the multiple genetic elements in the Xic is also being obtained by the analysis of sequence variation and conservation in the Xic. This is being explored in collaboration with the Genoscope (Evry) and Laurent Duret (Lyon University) in a project involving the in-depth sequencing and annotation of the Xic of seven mammalian species.
A better understanding of some of the processes involved in the initiation of X-inactivation is likely to depend on combining such genetic and cell biology approaches with a detailed analysis of chromatin structure. Several different approaches to such an analysis including ChIP (Chromatin Immunoprecipitation) have been established in the laboratory. An example of such an approach is a recent study involving Chromatin immunoprecipitation (ChiP) analysis of ES strains carrying genetically engineeered modifications of the 3' part of the Xic which has established that the Xist antisense transcript Tsix affects Xist transcription indirectly, rather than directly, through its effects on chromatin structure and especially chromatin structure around the Xist promoter. ChIP studies have also proved of great importance in characterising the role played by H3 histone modifications in the earliest stages of X-inactivation and have allowed us to define a region 5' to Xist which may act as a nucleation centre allowing the inactivation to spread from the Xic over the whole X chromosome. The elements defined by these studies are being further characterised by genetic modification and analysis ex vivo and in vivo of the resulting material.
Our analysis of trans-acting genetic factors involved in the X-inactivation process has been recentred around facteurs involved in RNA metabolism and/or genes showing expression differences between 6.5 dpc female and male embryos in the SAGE (Serial Analysis of Gene Expression) analysis we have undertaken. Our functional analysis approach to these candidates involves RNAi vectors allowing stable expression and observation of altered X-inactivation parameters.
Genome Research and Mouse Disease Models
2) The Genetic analysis of type 1 diabetes
Another of the Unit's interest concerns the study of mouse phenotypes under multifactorial and polygenic control. We have taken as our prototype type 1 diabetes or insulin- dependent diabetes for which the NOD mouse represents an interesting model. Our studies are aimed at defining the genetic factors (Idd) implicated in this pathology which is known to depend on a complex interaction between environmental and genetic factors. Our studies are concentrated on the characterisation of Idd loci controlling diabetes susceptibility/resistance locating to the distal part of mouse chromosome 6. The past year has seen major advances in the definition and localisation of three loci Idd6, Idd19 and Idd20 lying in the distal part of mouse chromosome 6.
The continued refining of the candidate regions for these loci by establishment of congenic mouse strains has allowed candidate gene approaches to be undertaken to defining and characterising the genes responsible for these traits and in particular for Idd6. The immunological characterisation of our congenic strains has allowed the definition of the site of action/tissue involved in resistance to diabetes onset conferred by the Idd6 locus. Varied approaches including transcriptional profiling have exploited these results and this has allowed five candidate genes for the Idd6 locus to be defined. These are currently under functional analysis using RNAi lentivirus based approaches.
3) Stem Cells and the role of the X-linked gene Nap1l2
A second disease subject to both environmental and complex genetic control is spina bifida. In the mouse spina bifida can be induced by mutation in the X-linked Nap1l2 gene. Mutations in this gene are associated with embryonic lethality, spina bifida and exencephaly linked to a massive overproliferation of neuronal cells. We have now been able to obtain conditional mutations in the Nap1l2 gene and these are being exploited to explore its role in the adult. The recent establishment of a highly efficient system for differentiating ES cells into neural stem cells and cells of the neuronal lineage has opened up interesting perspective for understanding the role and mechanism of action of this gene, its interactions and its cellular partners. Both expression analysis using microarrays and biochemical approaches to Nap1l2 gene function and interactions are being facilitated by the availability of purified cell populations.
Keywords: Epigenetics, X chromosome inactivation, Chromatin, Genetics, Genomics, Type 1 Diabetes, Mouse, QTL, Multigenic inheritance, Stem cells
|More informations on our web site|
|Publications 2004 of the unit on Pasteur's references database|
|Office staff||Researchers||Scientific trainees||Other personnel|
|Vacant email@example.com||AVNER Philip Unit Head - INSTITUT PASTEUR, firstname.lastname@example.org
CNRS - DR1
CLERC Philippe INSTITUT PASTEUR –
Senior Staff Scientist and Laboratory
Head at the Institut Pasteur email@example.com
ROGNER Ute CNRS - Senior Staff Scientist firstname.lastname@example.org
ROUGEULLE Claire CNRS - Senior Staff Scientist email@example.com
|ATTIA Mikael Master 2 Student – Paris XI firstname.lastname@example.org
BRUTSAERT Siska Post-doctoral fellow email@example.com
CHANTALAT Sophie Post-doctoral fellow firstname.lastname@example.org
CIAUDO Constance PhD student email@example.com
NAUMANN Frauke Post-doctoral fellow firstname.lastname@example.org
NAVARRO Pablo PhD student email@example.com
PAGE Damien Post-doctoral fellow firstname.lastname@example.org
VIGNEAU Sébastien PhD student email@example.com
|CHUREAU Corinne IP – « Ingénieur » firstname.lastname@example.org
PICHARD Sylvain IP – Technician email@example.com
VERON Corinne IP - Research support staff firstname.lastname@example.org